Page last updated: 2024-08-22
tiletamine hydrochloride and sphingosine kinase
tiletamine hydrochloride has been researched along with sphingosine kinase in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, MB; Jin, ZC; Wang, Y; Xu, LJ; Xu, M; Yang, DR; Zhou, LN; Zhu, J | 1 |
Other Studies
1 other study(ies) available for tiletamine hydrochloride and sphingosine kinase
Article | Year |
---|---|
The therapeutic value of SC66 in human renal cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclohexanones; Female; Humans; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Mice, SCID; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinase; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |